A role for glucocorticoid-signaling in depression-like behavior of gastrin-releasing peptide receptor knock-out mice

Annals of Medicine

Volumn 43, Issue 5, 2011, Pages 389-402

  Monje, Francisco J ^a   Kim, Eun Jung ^a,b   Cabatic, Maureen ^a   Lubec, Gert ^b   Herkner, Kurt R ^b   Pollak, Daniela D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

Author keywords

Amygdala; behavior; depression; glucocorticoid; laser capture microdissection; microarray

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; GASTRIN RELEASING PEPTIDE RECEPTOR; GLUCOCORTICOID; MESSENGER RNA;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; DEPRESSION; FORCED SWIMMING TEST; GENE EXPRESSION; KNOCKOUT MOUSE; LASER CAPTURE MICRODISSECTION; LEARNING; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE;

AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; CORTICOSTERONE; DEPRESSION; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE DELETION; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; RECEPTORS, BOMBESIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79959350849     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.538716     Document Type: Article

References (49)

1. Ladenheim EE, Jensen RT, Mantey SA, Moran TH. Distinct distributions of two bombesin receptor subtypes in the rat central nervous system. Brain research. 1992;593:168-78.
2. Houben H, Andries M, Denef C. Autoradiographic demonstration of 125I-Tyr4-bombesin binding sites on rat anterior pituitary cells. Peptides. 1994;15:1289-95.
3. Marcilhac A, Siaud P. Identifi cation of projections from the central nucleus of the amygdala to the paraventricular nucleus of the hypothalamus which are immunoreactive for corticotrophin-releasing hormone in the rat. Experimental physiology. 1997;82:273-81. (Pubitemid 27182304)
4. Shumyatsky GP, Tsvetkov E, Malleret G, Vronskaya S, Hatton M, Hampton L, et al. Identifi cation of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifi cally related to learned fear. Cell. 2002;111:905-18. (Pubitemid 36106409)
5. Luft T, Flores DG, Vianna MR, Schwartsmann G, Roesler R, Izquierdo I. A role for hippocampal gastrin-releasing peptide receptors in extinction of aversive memory. Neuroreport. 2006;17:935-9. (Pubitemid 43869962)
6. Mountney C, Sillberg V, Kent P, Anisman H, Merali Z. The role of gastrin-releasing peptide on conditioned fear: differential cortical and amygdaloid responses in the rat. Psychopharmacology. 2006;189:287-96. (Pubitemid 44772812)
7. Roesler R, Henriques JA, Schwartsmann G. Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders. CNS Neurol Disord Drug Targets. 2006;5:197-204. (Pubitemid 43796620)
8. Kessler RC, Gruber M, Hettema JM, Hwang I, Sampson N, Yonkers KA. Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychol Med. 2008;38:365-74. (Pubitemid 351311682)
9. Hettema JM. What is the genetic relationship between anxiety and depression? Am J Med Genet C Semin Med Genet. 2008;148C:140-6. (Pubitemid 351705131)
10. Hampton LL, Ladenheim EE, Akeson M, Way JM, Weber HC, Sutliff VE, et al. Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-defi cient mice. Proc Natl Acad Sci USA. 1998;95:3188-92. (Pubitemid 28135877)
11. Venturella R, Lessa D, Luft T, Roozendaal B, Schwartsmann G, Roesler R. Dexamethasone reverses the memory impairment induced by antagonism of hippocampal gastrin-releasing peptide receptors. Peptides. 2005;26:821-5. (Pubitemid 40461663)
12. Pollak DD, Monje FJ, Zuckerman L, Denny CA, Drew MR, Kandel ER. An animal model of a behavioral intervention for depression. Neuron. 2008;60:149-61.
13. Lim WK, Wang K, Lefebvre C, Califano A. Comparative analysis of microarray normalization procedures: effects on reverse engineering gene networks. Bioinformatics. 2007; 23:282-8.
14. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics. 2003;19:368-75. (Pubitemid 36284936)
15. Cai Y, Liu Y, Zhang X. Induction of transcription factor Egr-1 gene expression in astrocytoma cells by Murine coronavirus infection. Virology. 2006;355:152-63. (Pubitemid 44692773)
16. Kim KS, Lee KW, Baek IS, Lim CM, Krishnan V, Lee JK, et al. Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior. J Neurochem. 2008; 107:105-15.
17. Pondugula SR, Raveendran NN, Ergonul Z, Deng Y, Chen J, Sanneman JD, et al. Glucocorticoid regulation of genes in the amiloride-sensitive sodium transport pathway by semicircular canal duct epithelium of neonatal rat. Physiol Genomics. 2006;24:114-23.
18. Zheng F, Luo Y, Wang H. Regulation of brain-derived neurotrophic factor-mediated transcription of the immediate early gene Arc by intracellular calcium and calmodulin. J Neurosci Res. 2009;87:380-92.
19. Muller MB, Keck ME, Binder EB, Kresse AE, Hagemeyer TP, Landgraf R, et al. ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic- pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology. 2003;28:1991-9. (Pubitemid 37412108)
20. Aida R, Moriya T, Araki M, Akiyama M, Wada K, Wada E, et al. Gastrin-releasing peptide mediates photic entrainable signals to dorsal subsets of suprachiasmatic nucleus via induction of Period gene in mice. Mol Pharmacol. 2002;61: 26-34. (Pubitemid 34049509)
21. Karatsoreos IN, Romeo RD, McEwen BS, Silver R. Diurnal regulation of the gastrin-releasing peptide receptor in the mouse circadian clock. Eur J Neurosci. 2006;23:1047-53. (Pubitemid 43344699)
22. N ovak J, Schleman S, Scott J, Balderman VL, Krech L, Kane MA. Dexamethasone regulation of gastrin-releasing peptide receptor in human lung cells. Lung Cancer. 2004;43:17-28. (Pubitemid 38096288)
23. Buse P, Maiyar AC, Failor KL, Tran S, Leong ML, Firestone GL. The stimulus-dependent co-localization of serum- and glucocorticoid-regulated protein kinase (Sgk) and Erk/MAPK in mammary tumor cells involves the mutual interaction with the importin-alpha nuclear import protein. Exp Cell Res. 2007;313:3261-75. (Pubitemid 47284067)
24. Sato H, Horikawa Y, Iizuka K, Sakurai N, Tanaka T, Shihara N, et al. Large-scale analysis of glucocorticoid target genes in rat hypothalamus. J Neurochem. 2008;106:805-14.
25. David S, Kalb RG. Serum/glucocorticoid-inducible kinase can phosphorylate the cyclic AMP response element binding protein, CREB. FEBS lett. 2005;579:1534-8. (Pubitemid 40289208)
26. David S, Stegenga SL, Hu P, Xiong G, Kerr E, Becker KB, et al. Expression of serum- and glucocorticoid-inducible kinase is regulated in an experience-dependent manner and can cause dendrite growth. J Neurosci. 2005;25:7048-53. (Pubitemid 41077013)
27. Carlezon WA Jr, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci. 2005;28:436-45. (Pubitemid 40982557)
28. Laifenfeld D, Karry R, Grauer E, Klein E, Ben-Shachar D. ATF2, a member of the CREB/ATF family of transcription factors, in chronic stress and consequent to antidepressant treatment: animal models and human post-mortem brains. Neuropsychopharmacology. 2004;29:589-97. (Pubitemid 38365936)
29. Tiraboschi E, Tardito D, Kasahara J, Moraschi S, Pruneri P, Gennarelli M, et al. Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology. 2004;29:1831-40. (Pubitemid 39336795)
30. Sairanen M, O'L eary OF, Knuuttila JE, Castren E. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience. 2007;144: 368-74. (Pubitemid 44839045)
31. Revest JM, Di Blasi F, Kitchener P, Rouge-Pont F, Desmedt A, Turiault M, et al. The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids. Nat Neurosci. 2005;8:664-72. (Pubitemid 40594209)
32. Knapska E, Kaczmarek L. A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox- 24/TIS8/ZENK? Prog Neurobiol. 2004;74:183-211. (Pubitemid 39535508)
33. Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology. 2008;33:88-109. (Pubitemid 350191319)
34. Sillaber I, Panhuysen M, Henniger MS, Ohl F, Kuhne C, Putz B, et al. Profi ling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology. 2008;200:557-72.
35. B ramham CR, Worley PF, Moore MJ, Guzowski JF. The immediate early gene arc/arg3.1: regulation, mechanisms, and function. J Neurosci. 2008;28:11760-7.
36. McReynolds JR, Donowho K, Abdi A, McGaugh JL, Roozendaal B, McIntyre CK. Memory-enhancing corticosterone treatment increases amygdala norepinephrine and Arc protein expression in hippocampal synaptic fractions. Neurobiol Learn Mem. 2010;93:312-21.
37. Elizalde N, Pastor PM, Garcia-Garcia AL, Serres F, Venzala E, Huarte J, et al. Regulation of markers of synaptic function in mouse models of depression: chronic mild stress and decreased expression of VGLUT1. J Neurochem. 2010; 114:1302-14.
38. Molteni R, Calabrese F, Maj PF, Olivier JD, Racagni G, Ellenbroek BA, et al. Altered expression and modulation of activity-regulated cytoskeletal associated protein (Arc) in serotonin transporter knockout rats. Eur Neuropsychopharmacol. 2009;19:898-904.
39. Molteni R, Chourbaji S, Brandwein C, Racagni G, Gass P, Riva MA. Depression-prone mice with reduced glucocorticoid receptor expression display an altered stress-dependent regulation of brain-derived neurotrophic factor and activityregulated cytoskeleton-associated protein. J Psychopharmacol. 2010;24:595-603.
40. Alme MN, Wibrand K, Dagestad G, Bramham CR. Chronic fluoxetine treatment induces brain region-specifi c upregulation of genes associated with BDNF-induced long-term potentiation. Neural Plast. 2007;2007:26496.
41. Larsen MH, Olesen M, Woldbye DP, Hay-Schmidt A, Hansen HH, Ronn LC, et al. Regulation of activity-regulated cytoskeleton protein (Arc) mRNA after acute and chronic electroconvulsive stimulation in the rat. Brain Res. 2005;1064:161-5. (Pubitemid 41774656)
42. Shur I, Socher R, Benayahu D. Dexamethasone regulation of cFos mRNA in osteoprogenitors. J Cell Physiol. 2005; 202:240-5. (Pubitemid 39603381)
43. Wei P, Vedeckis WV. Regulation of the glucocorticoid receptor gene by the AP-1 transcription factor. Endocrine. 1997; 7:303-10. (Pubitemid 28223936)
44. Herrera DG, Robertson HA. Activation of c-fos in the brain. Prog Neurobiol. 1996;50:83-107. (Pubitemid 26412595)
45. Raison CL, Miller AH. When not enough is too much: the role of insuffi cient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry. 2003;160:1554-65. (Pubitemid 41079539)
46. Garrido MM, Martin S, Ambrosio E, Fuentes JA, Manzanares J. Role of corticotropin-releasing hormone in gastrin-releasing peptide-mediated regulation of corticotropin and corticosterone secretion in male rats. Neuroendocrinology. 1998;68:116-22. (Pubitemid 28383255)
47. Brown MR, Carver K, Fisher LA. Bombesin: central nervous system actions to affect the autonomic nervous system. Ann N Y Acad Sci. 1988;547:174-82.
48. Okuma Y, Yokotani K, Osumi Y. Brain prostaglandins mediate the bombesin-induced increase in plasma levels of catecholamines. Life Sci. 1996;59: 1217-25. (Pubitemid 26322919)
49. Ishida A, Mutoh T, Ueyama T, Bando H, Masubuchi S, Nakahara D, et al. Light activates the adrenal gland: timing of gene expression and glucocorticoid release. Cell Metab. 2005;2:297-307.